NCT04678583

Brief Summary

the ARMANI trial will test the hypothesis, if an anatomic resection (AR) improves long-term outcome vs. a non-anatomical resection (NAR) in patients undergoing surgery for RAS-mutated colorectal liver metastasis (CRLM).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
19mo left

Started Jan 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

37 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Jan 2021Dec 2027

First Submitted

Initial submission to the registry

October 30, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 22, 2020

Completed
10 days until next milestone

Study Start

First participant enrolled

January 1, 2021

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

June 13, 2024

Status Verified

June 1, 2024

Enrollment Period

6.9 years

First QC Date

October 30, 2020

Last Update Submit

June 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intrahepatic disease-free survival (iDFS)

    Time from operation date to date of disease recurrence in the liver, followed up at intervals of three months for a maximum duration of 24 months or until death. Any new, solid lesion in the liver after resection of all CRLM that fulfils imaging criteria (CT, MRI) of a metastasis is counted as an iDFS event.

    24 months

Secondary Outcomes (25)

  • Assessment of additional oncological and perioperative outcomes: Intraoperative blood loss [mL]

    During surgery

  • Assessment of additional oncological and perioperative outcomes: Operating time [min]

    During surgery

  • Assessment of additional oncological and perioperative outcomes: Transfusion of blood, transfused packed red blood cells (PRBC), fresh frozen plasma (FFP) and / or platelet concentrate (PC) [units]

    48 hours after surgery

  • Assessment of additional oncological and perioperative outcomes: Duration of postoperative hospital stay [days]

    At day of discharge, assessed up to 90 days

  • Assessment of additional oncological and perioperative outcomes: Duration of postoperative intermediate/intensive care unit stay [days]

    At day of discharge, assessed up to 90 days

  • +20 more secondary outcomes

Study Arms (2)

A - Anatomical resection

EXPERIMENTAL

removal of the entire, tumor-bearing liver segment(s)

Procedure: Resection of colorectal liver metastases

B - Non-anatomical resection

ACTIVE COMPARATOR

metastasectomy with a margin of healthy liver tissue irrespective of segmental borders

Procedure: Resection of colorectal liver metastases

Interventions

Comparison of two liver surgery methods

A - Anatomical resectionB - Non-anatomical resection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Colorectal cancer with RAS mutation (KRAS or NRAS)
  • Colorectal liver metastases (single or multiple)
  • Planned R0 resection of liver metastases (and primary tumor, if present)
  • Anatomical and non-anatomical liver resection technically feasible
  • Male and female patients, age ≥ 18 years
  • Written informed consent

You may not qualify if:

  • Extrahepatic metastases
  • Planned staged liver resection (e.g. two-stage hepatectomy)
  • Diagnosis of another cancer \< 5 years prior to randomization Exceptions: curatively treated in situ cervical cancer, curatively resected non-melanoma skin cancer
  • Expected lack of compliance
  • Addiction or other illnesses which do not allow the person concerned to assess the nature and extent of the clinical trial and its possible consequences

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (37)

Department of Surgery at the University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University

Mannheim, Baden-Wurttemberg, 68167, Germany

RECRUITING

Department of Gastrointestinal-, Thoracic and Vascular Surgery University Hospital Carl Gustav Carus Technische Universität Dresden

Dresden, Saxony, 01307, Germany

RECRUITING

Intestinal Center West Middle Franconia, ANregiomed Clinic Ansbach

Ansbach, Germany

RECRUITING

Clinic for General, Vizeral and Transplant Surgery, Augsburg University Hospital

Augsburg, Germany

RECRUITING

Department of General, Visceral and Vascular Surgery, Charité, University Medicine Berlin, Campus Benjamin Franklin Berlin

Berlin, Germany

RECRUITING

Clinic and Polyclinic for General, Visceral, Thoracic and Vascular Surgery, University Hospital Bonn

Bonn, Germany

RECRUITING

Surgical Clinic, Municipal Hospital Braunschweig gGmbH

Braunschweig, Germany

RECRUITING

Cancer Center, Helios Amper-Hospital Dachau

Dachau, Germany

RECRUITING

Surgical Clinic, Dortmund Hospital

Dortmund, Germany

RECRUITING

Clinic for General and Visceral Surgery, Municipal Hospital Dresden

Dresden, Germany

RECRUITING

Clinic for General, Visceral and Pediatric Surgery, University Hospital Düsseldorf

Düsseldorf, Germany

RECRUITING

Surgical Clinic, University Hospital Erlangen

Erlangen, Germany

RECRUITING

Clinic for General, Visceral and Transplant Surgery, University Hospital Frankfurt, Goethe University Frankfurt am Main

Frankfurt, Germany

RECRUITING

Department for General and Visceral Surgery, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg

Freiburg im Breisgau, Germany

RECRUITING

JLU Gießen, Department for General, Visceral, Thoracic and Transplant Surgery

Giessen, Germany

RECRUITING

Clinic for General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Georg-August-University

Göttingen, Germany

RECRUITING

Clinic and Polyclinic for General Surgery, Department of Gastrointestinal, Thoracic and Vascular Surgery, University Greifswald, University Hospital Greifswald

Greifswald, Germany

RECRUITING

University Hospital and Polyclinic for Visceral, Vascular and Endocrine Surgery, University Hospital Halle (Saale)

Halle, Germany

RECRUITING

Center for Surgical Medicine - Clinic and Polyclinic for General, Visceral and Thoracic Surgery, University Hospital Hamburg-Eppendorf

Hamburg, Germany

RECRUITING

Department of Liver, Bile Duct and Pancreas Surgery, University Department of surgery, Asklepios Klinik Barmbek

Hamburg, Germany

RECRUITING

Clinic for General, Visceral and Minimally Invasive Surgery, KRH Clinic Siloah, Hannover

Hanover, Germany

RECRUITING

Medizinische Hochschule Hannover, Department of General, Visceral and Transplant Surgery

Hanover, Germany

RECRUITING

Department of General, Visceral and Transplantation Surgery, University of Heidelberg

Heidelberg, Germany

RECRUITING

General Visceral and Vascular Surgery, Jena University Medical Center

Jena, Germany

RECRUITING

Clinic for Surgery, University Hospital Schleswig-Holstein Lübeck Campus

Lübeck, Germany

RECRUITING

University Department of General, Visceral, Vascular and Transplant Surgery, Faculty of Medicine, Otto von Guericke University Magdeburg

Magdeburg, Germany

RECRUITING

Clinic for General, Visceral and Transplantation Surgery, University Medical Center of the Johannes Gutenberg-University Mainz

Mainz, Germany

RECRUITING

Clinic for Visceral, Thoracic and Vascular Surgery, University Hospital Giessen and Marburg

Marburg, Germany

RECRUITING

LMU Munich Hospital, Clinic for General, Visceral and Transplant Surgery

Munich, Germany

RECRUITING

Department Hepato-Pancreato-Biliary Surgery, Barmherzige Brüder gGmbH of the Hospital Barmherzige Brüder Munich

München, Germany

RECRUITING

Department of Surgery, University Hospital rechts der Isar

München, Germany

RECRUITING

Clinic for General, Visceral and Transplant Surgery, University of Münster

Münster, Germany

RECRUITING

University Hospital for General and Visceral Surgery, Oldenburg Hospital

Oldenburg, Germany

WITHDRAWN

Department of General, Visceral and Transplant Surgery, University of Tübingen, Comprehensive Cancer Center

Tübingen, Germany

RECRUITING

Clinic for General and Visceral Surgery, Ulm University Medical Center

Ulm, Germany

RECRUITING

General and Visceral Surgery, Helios University Medical Center Wuppertal, University Witten/Herdecke

Wuppertal, Germany

RECRUITING

Department for General, Visceral, Transplant, Vascular and Pediatric Surgery, Julius-Maximilian-University Würzburg, University Hospital Würzburg

Würzburg, Germany

RECRUITING

Study Officials

  • Jürgen Weitz, Prof Dr med

    Department of Gastrointestinal-, Thoracic and Vascular Surgery, University Hospital CGC

    PRINCIPAL INVESTIGATOR
  • Nuh Rahbari, Prof Dr med

    Allgemein- und Viszeralchirugie, University Hospital Ulm

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jürgen Weitz, Prof Dr med

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized, controlled, patient and observer-blinded, confirmatory trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2020

First Posted

December 22, 2020

Study Start

January 1, 2021

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

June 13, 2024

Record last verified: 2024-06

Locations